0000000000116892

AUTHOR

Jörg Petersen

showing 4 related works from this author

Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers.

2007

In recent years, a large number of groups studied the fate of human stem cells in livers of immunodeficient animals. However, the interpretation of the results is quite controversial. We transplanted 4 different types of human extrahepatic precursor cells (derived from cord blood, monocytes, bone marrow, and pancreas) into livers of nonobese diabetic/severe combined immunodeficiency mice. Human hepatocytes were used as positive controls. Tracking of the transplanted human cells could be achieved by in situ hybridization with alu probes. Cells with alu-positive nuclei stained positive for human albumin and glycogen. Both markers were negative before transplantation. However, cells with alu-p…

Pathologymedicine.medical_specialtyCell typeLiver cytologyCellular differentiationTransplantation HeterologousMice SCIDBiologyStammzelleMiceMice Inbred NODPrecursor cellAlbuminsmedicineAnimalsHumansHepatologyStem CellsTransdifferentiationCell DifferentiationGentransferCell biologyTransplantationmedicine.anatomical_structureLiverBone marrowStem cellStem Cell TransplantationHepatology (Baltimore, Md.)
researchProduct

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2…

2019

Norursodeoxycholic acid is an orally administered side chain-shortened homologue of ursodeoxycholic acid that undergoes hepatic enrichment with hepatoprotective, anti-inflammatory, and antifibrotic activity. We assessed the efficacy of two doses of norursodeoxycholic acid versus placebo for the treatment of non-alcoholic fatty liver disease.We did a multicentre, double-blind, placebo-controlled, randomised, phase 2 dose-finding clinical trial in tertiary referral hospitals and medical centres in Austria (n=6) and Germany (n=23) for patients with non-alcoholic fatty liver disease with or without diabetes. Patients with a clinical diagnosis of non-alcoholic fatty liver disease and serum alani…

AdultBlood GlucoseMalemedicine.medical_specialtyCholagogues and CholereticsPopulationPlaceboGastroenterologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawNon-alcoholic Fatty Liver DiseaseDiabetes mellitusInternal medicinemedicineHumansAspartate Aminotransferaseseducationeducation.field_of_studyHepatologyDose-Response Relationship Drugbusiness.industryFatty liverUrsodeoxycholic AcidGastroenterologyAlanine TransaminaseMiddle Agedmedicine.diseaseLipidsUrsodeoxycholic acidClinical trialDose–response relationshipTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemalebusinessmedicine.drugThe lancet. Gastroenterologyhepatology
researchProduct

Reliability and effectiveness of Ellenberg’s indices in checking flora and vegetation changes induced by climatic variations

2001

Two methods are proposed to assess the significance of time-spanned local variations of Ellenberg’s indicator values in floristic and phytosociological data sets respectively. Both methods are based on frequencies and averages of the indicator values within and among data sets. Main goal of proposed methods is to determine the threshold above which the observed variations are to be considered significant. In order to relate the observed floristic variations to recent climatic changes, attention was focused on the Ellenberg’s indices dealing with the main climatic variables: heliophany, temperature and precipitation. Study-cases from Zannone Island (Pontine Archipelago, Mediterranean region)…

HydrologyMediterranean climategeographygeography.geographical_feature_categoryNational parkPlant communityVegetationFloristicsEllenberg indices flora vegetation Mediterranean region Alpine region climatic changesSettore BIO/03 - Botanica Ambientale E ApplicataArchipelagoEnvironmental sciencePrecipitationPhysical geographyIndicator value
researchProduct

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

2010

Tenofovir disoproxil fumarate (TDF) has demonstrated high antiviral efficacy in treatment-naive patients with chronic hepatitis B virus (HBV) infection but experience in nucleoside/nucleotide analogue (NA)-experienced patients is limited. In this retrospective multicenter study we therefore assessed the long-term efficacy of TDF monotherapy in patients with prior failure or resistance to different NA treatments. Criteria for inclusion were HBV DNA levels >4.0 log(10) copies/mL at the start and a minimum, period of TDF therapy for at least 6 months. In all, 131 patients (mean age 42 +/- 12 years, 95 male, 65% hepatitis B e antigen [HBeAg]-positive) were eligible. Pretreatment consisted of…

AdultMalemedicine.medical_specialtyHBsAgAdolescentOrganophosphonatesPharmacologyBiologymedicine.disease_causeGastroenterologyCohort StudiesSDG 3 - Good Health and Well-beingInternal medicineDrug Resistance ViralmedicineAdefovirHumansHepatitis B e AntigensTenofovirRetrospective StudiesHepatitis B virusHepatitis B Surface AntigensHepatologyReverse-transcriptase inhibitorAdenineLamivudinevirus diseasesEntecavirHepatitis BMiddle Agedmedicine.diseaseHepatitis BTreatment OutcomeHBeAgLamivudineFemalemedicine.drugHepatology
researchProduct